<0> SAFE-BioPharma AssociationJon Weisberg, 801-359-9977Mobile: 801-860-9977 </0>
Four pharmaceutical executives have been elected to the Board of Directors of SAFE-BioPharma Association, the strategic non-profit collaboration that developed and manages the global SAFE-BioPharma® digital identity and digital signature standard for the life science and healthcare sectors. The association’s members include most of the world’s largest biopharmaceutical companies.
The SAFE-BioPharma standard is used throughout the biopharmaceutical and healthcare industries to manage high assurance digital identities and to apply legally-binding digital signatures to electronic documents.
The four new directors are:
The all-volunteer Board participates in establishing the association’s goals, which include global expansion of the SAFE-BioPharma standard among biopharmaceutical industry partners and the U.S. healthcare system and its acceptance by governments and research institutions.
“Each of the new directors, brings specific talents to SAFE-BioPharma. They will complement our longer serving board members in providing effective governance of the standard,” said Mollie Shields-Uehling, president and CEO and a director of SAFE-BioPharma Association.
For more information on the SAFE-BioPharma standard for digital identity and digital signatures used in life science and healthcare settings, visit .
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.